Knee Osteoarthritis. Gonarthrosis [arthrosis of knee]
Conditions
Interventions
Intervention 1: Patients participating in the study will be divided into two groups of 70 people. One group will take 40 mg Depomedrol corticosteroid injection in the space between the knee joint
Treatment - Drugs
intervention group: hyaluronic acid (Hyalgan) in 2 ml vials to the space between the knee joint by an orthopedic physician
control group: this group will take 40 mg Depomedrol corticosteroid injection in the space between the knee joint by an orthopedic physician
Patients participating in the study will be divided into two groups of 70 people. One group will take 40 mg Depomedrol corticosteroid injection in the space between the knee joint by an orthopedic
Sponsors
Vice Chancellor for research of Fasa University of Medical Sciences
Eligibility
Sex/Gender
All
Age
48 Years to 13 Years
Inclusion criteria
Inclusion criteria: Qualified patients were men and women from 45 years to 80 years of age suffering from knee OA for more than 3 months, with radiographic. Main exclusion criteria were a history or presence of trauma or surgery or cancer or malignant tumors, infections and sores on the target knee, History of vasovagal shock , The use of NSAIDs in 2 days prior to injection, Any receiving corticosteroids injection in the knee in the last 6 months , Pregnancy and lactation
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: before intervention- one- two- three months after intervention. Method of measurement: Visual analogue scale and questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical function. Timepoint: before and after intervention. Method of measurement: questionnaire and interview with patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Alireza Askari
Fasa University of Medical Sciences
Outcome results
None listed